APEX1 and hepatocellular carcinoma: When we analyzed the correlation of APEX1 expression with HCC patient survival in this way, the results suggested that patients with high APEX1 expression exhibited a lower 5-year survival rate compared with those with low APEX1 expression (Figure 2).